Browse Drug Recalls

3,368 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 3,368 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 3,368 FDA drug recalls.

Clear
DateProductReasonClassFirm
Apr 24, 2025 Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Min... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Min... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Kingskin, SacaCallos, 17% Salicylic acid, 0.5 fl oz (14.8mL) Bottle, Dist. by... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Rapidol Maximum Strength, Hydrocortisone 1% Anti-Itch Cream, NET WT 2 oz (60g... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Artridon Glucosamine (menthol 2% and Methyl Salicylate 15% - Topical Analgesi... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Optim V, Anti-Itch Cream, Benzocaine 20% & Resorcinol 3% - External analgesic... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Maximum Security Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Min... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Nature Mint Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%,... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 24, 2025 Nature Mint Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%,... CGMP Deviations Class II KENIL HEALTHCARE PRIVATE LIMITED
Apr 23, 2025 Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Carboxymethlycellulos... cGMP deviations and lack of assurance of sterility. Class II BRS Analytical Services, LLC
Apr 23, 2025 Lubricant Eye Drops Solution, Polyethylene Glycol 400 0.4% Eye Lubricant, Pro... cGMP deviations and lack of assurance of sterility. Class II BRS Analytical Services, LLC
Apr 23, 2025 Polyvinyl Alcohol Ophthalmic Solution 1.4%, Lubricant Eye Drops, Moisturizing... cGMP deviations and lack of assurance of sterility. Class II BRS Analytical Services, LLC
Apr 23, 2025 Carboxymethylcellulose Sodium Ophthalmic Gel 1%, Carboxymethlycellulose Sodiu... cGMP deviations and lack of assurance of sterility. Class II BRS Analytical Services, LLC
Apr 23, 2025 Artificial Tears Ophthalmic Solution, Dextran 70.01%/Glycerin 0.2%/Hypromello... cGMP deviations and lack of assurance of sterility. Class II BRS Analytical Services, LLC
Apr 22, 2025 Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repack... CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets. Class II RemedyRePack Inc.
Apr 21, 2025 PROLIA (denosumab), injection, 60mg/mL, For Subcutaneous Use Only, Rx Only, M... CGMP Deviations; potential temperature excursions due to transit delays Class II Mckesson Medical-Surgical Inc. Corporate Office
Apr 21, 2025 BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-10... CGMP Deviations; potential temperature excursions due to transit delays Class II Mckesson Medical-Surgical Inc. Corporate Office
Apr 21, 2025 EVENITY, (romosozumab -aqqg) injection, 105mg/1.17 mL, For Subcutaneous Use O... CGMP Deviations; potential temperature excursions due to transit delays Class II Mckesson Medical-Surgical Inc. Corporate Office
Apr 18, 2025 Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufacture... cGMP Deviations Class II Preferred Pharmaceuticals, Inc.
Apr 15, 2025 Rapidol Arnica Tablets, Homeopathic Medicine, 100-count bottle, Distributed b... cGMP deviations Class II Pharmadel, LLC
Apr 15, 2025 DoloEar Earache Drops, Homeopathic, 0.50 oz fl (15 mL), Distributed by: Pharm... cGMP deviations Class II Pharmadel, LLC
Apr 15, 2025 Rapidol Arnica Gel, Topical Gel, Homeopathic Medicine, 2 oz (57 g), Distribut... cGMP deviations Class II Pharmadel, LLC
Apr 15, 2025 Kingskin, Elimina Las Verrugas, For the removal of common warts, 0.50 oz fl (... cGMP deviations Class II Pharmadel, LLC
Apr 15, 2025 DoloDent Maximum Strength Toothache Drops, Homeopathic Oral Drops, 0.50 oz fl... cGMP deviations Class II Pharmadel, LLC
Apr 15, 2025 Urodel, Urinary Tract Infection Symptoms Relief, Homeopathic, 30 chewable tab... cGMP deviations Class II Pharmadel, LLC
Apr 14, 2025 ChlorproMAZINE Hydrochloride Tablets, USP, 10 mg, packaged in cartons of 100 ... CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended in... Class II The Harvard Drug Group LLC dba Major Pharmaceut...
Apr 14, 2025 Duloxetine Delayed-Release Capsules USP, 30 mg, a.) 90-count bottles (NDC# 51... CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed inter... Class II Breckenridge Pharmaceutical, Inc
Apr 14, 2025 Duloxetine Delayed-Release Capsules USP, 60 mg, 1000-count bottles, Rx Only, ... CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed inter... Class II Breckenridge Pharmaceutical, Inc
Apr 10, 2025 Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Singl... cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials. Class II Eugia US LLC
Apr 9, 2025 Kapsin Ointment, Camphor 3.16% and Capsaicin 0.03%. Net Wt. 2 oz (60g) tubes,... CGMP Deviations Class II Apipharma
Apr 9, 2025 Hemopropin Ointment, Lanolin 17.76% and Petrolatum 71.2%, Net Wt. 0.7 oz (20g... CGMP Deviations Class II Apipharma
Apr 3, 2025 chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles... CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended in... Class II Zydus Pharmaceuticals (USA) Inc
Mar 31, 2025 Bimatoprost powder, Bulk Ingredient, a) 5g (NDC 38779-3066-03), b) 1g (NDC 38... CGMP Deviations Class II Medisca Inc.
Mar 26, 2025 Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 1,000 Capsules per ... CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-dulox... Class II Breckenridge Pharmaceutical, Inc.
Mar 26, 2025 Unisom, SleepMinis, Diphenhydramine HCl, Mini-Capsules, 25 mg, 60 Mini-Capsul... CGMP Deviations; detection of Nitrosamine Drug Substance-Related Impurities (NDSRI), N-nitroso-de... Class II Chattem Inc
Mar 24, 2025 Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repack... CGMP Deviations Class II RemedyRepack Inc.
Mar 24, 2025 Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 i... cGMP Deviations: Received notification from their supplier requesting they perform a recall due t... Class II Amerisource Health Services LLC
Mar 13, 2025 Fluphenazine Hydrochloride Tablets 2.5mg, 100-count bottle, Rx Only, Manufact... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Mar 13, 2025 Teriflunomide Tablets, 14mg, 30-count bottle, Rx Only, Manufactured by: Glenm... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Mar 13, 2025 Solifenacin Succinate Tablets 10MG, a. 30-count bottle (NDC# 68462-387-30), ... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Mar 13, 2025 Voriconazole Tablets 200 mg, 30-count bottle, Rx Only, Manufactured by: Glenm... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Mar 13, 2025 Propafenone Hydrochloride Extended-Release Capsules 225mg, 60-count bottle, R... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Mar 13, 2025 Lacosamide Tablets, 50mg, 60-count bottles, Rx Only, Manufactured by: Glenmar... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Mar 13, 2025 Nitroglycerin Sublingual Tablets 0.3MG, 100-count bottles, Manufactured by: G... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Mar 13, 2025 Clindamycin Hydrochloride Capsules, USP, 300mg, 100-count bottles, Manufactur... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Mar 13, 2025 Indomethacin Extended-Release Capsules, 75mg, 60-count bottles, Manufactured ... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA
Mar 13, 2025 Rosuvastatin Tablets 40mg, 30-count bottle, Rx Only, Manufactured by: Glenmar... CGMP Deviations Class II Glenmark Pharmaceuticals Inc., USA

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.